Literature DB >> 36006617

Fetal Left Ventricular Apical Aneurysm Progressing to Dilated Cardiomyopathy Due to Glycogen Storage Disease.

Geetha Challapudi1,2, Gerard J Boyle2, E Rene Rodriguez3, Rukmini Komarlu2.   

Abstract

Fetal dilated cardiomyopathy is a rare anomaly characterized by ventricular dilation and dysfunction. Its causes are diverse, and its outcomes are generally dismal. We describe a rare case of prenatally diagnosed left ventricular apical aneurysm that progressed rapidly to dilated cardiomyopathy. At age 2 months, the infant underwent heart transplantation. Pathologic examination of the explanted heart revealed that the cause of the dilated cardiomyopathy was glycogen storage disease. This case highlights the crucial roles of timely diagnosis, frequent close monitoring, and multidisciplinary care in achieving a successful postnatal outcome.
© 2022 by the Texas Heart® Institute, Houston.

Entities:  

Keywords:  Cardiomyopathy, dilated/diagnosis; delivery rooms/organization & administration; fetal diseases/diagnosis/diagnostic imaging/etiology/pathology/physiopathology; glycogen storage disease; heart ventricles; infant, newborn; prenatal diagnosis; treatment outcome; ultrasonography, prenatal

Mesh:

Year:  2022        PMID: 36006617      PMCID: PMC9427067          DOI: 10.14503/THIJ-20-7364

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  14 in total

1.  Prediction of outcome of fetal congenital heart disease using a cardiovascular profile score.

Authors:  A Wieczorek; J Hernandez-Robles; L Ewing; J Leshko; S Luther; J Huhta
Journal:  Ultrasound Obstet Gynecol       Date:  2008-03       Impact factor: 7.299

2.  Spectrum and outcome of primary cardiomyopathies diagnosed during fetal life.

Authors:  Roland Weber; Paul Kantor; David Chitayat; Mark K Friedberg; Fraser Golding; Luc Mertens; Lynne E Nield; Greg Ryan; Mike Seed; Shi-Joon Yoo; Cedric Manlhiot; Edgar Jaeggi
Journal:  JACC Heart Fail       Date:  2014-07-09       Impact factor: 12.035

3.  Dilated cardiomyopathy presenting during fetal life.

Authors:  Sivasubramonian Sivasankaran; Gurleen K Sharland; John M Simpson
Journal:  Cardiol Young       Date:  2005-08       Impact factor: 1.093

4.  Specialized delivery room planning for fetuses with critical congenital heart disease.

Authors:  Mary T Donofrio; Richard J Levy; Jennifer J Schuette; Kami Skurow-Todd; May-Britt Sten; Caroline Stallings; Jodi I Pike; Anita Krishnan; Kanishka Ratnayaka; Pranava Sinha; Adre J duPlessis; David S Downing; Melissa I Fries; John T Berger
Journal:  Am J Cardiol       Date:  2013-01-02       Impact factor: 2.778

Review 5.  Cardiac manifestations of inherited metabolic disease in children.

Authors:  David Fa Lloyd; Roshni Vara; Sujeev Mathur
Journal:  Pediatr Int       Date:  2017-05       Impact factor: 1.524

6.  Fetal cardiomyopathy--in utero evaluation and clinical significance.

Authors:  Yoav Yinon; Simcha Yagel; Juluis Hegesh; Boaz Weisz; Shali Mazaki-Tovi; Shlomo Lipitz; Reuven Achiron
Journal:  Prenat Diagn       Date:  2007-01       Impact factor: 3.050

7.  Spectrum of congenital heart disease detected echocardiographically in prenatal life.

Authors:  L D Allan; D C Crawford; R H Anderson; M Tynan
Journal:  Br Heart J       Date:  1985-11

8.  Fetal cardiomyopathies: pathogenic mechanisms, hemodynamic findings, and clinical outcome.

Authors:  Simone R F F Pedra; Jeffrey F Smallhorn; Greg Ryan; David Chitayat; Glenn P Taylor; Rubina Khan; Mohamed Abdolell; Lisa K Hornberger
Journal:  Circulation       Date:  2002-07-30       Impact factor: 29.690

9.  Diagnostic Approaches to Pediatric Cardiomyopathy of Metabolic Genetic Etiologies and Their Relation to Therapy.

Authors:  Gerald F Cox
Journal:  Prog Pediatr Cardiol       Date:  2007

10.  Case report: adult-onset manifesting heterozygous glycogen storage disease type IV with dilated cardiomyopathy and absent late gadolinium enhancement on cardiac magnetic resonance imaging.

Authors:  Shawn Lyo; Jeremy Miles; Jay Meisner; Mark Guelfguat
Journal:  Eur Heart J Case Rep       Date:  2020-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.